🎂 Billionaire Visionary Patrick Soon-Shiong: A Birthday Fit for a Medical Maverick

Happy 72nd birthday to Dr. Patrick Soon-Shiong, the South African-born surgical genius and biotech titan whose $8.8 billion fortune fuels a relentless quest to cure cancer. As the founder of NantWorks and a former surgeon who performed the first full-pancreas transplant, Soon-Shiong has spent decades blurring the lines between medicine, data, and philanthropy. His latest triumph? Pushing forward with groundbreaking immunotherapies and AI-driven diagnostics that promise to democratize treatment—all while owning the Los Angeles Times and championing journalistic integrity. At an age when most billionaires slow down, he’s just getting started.

Born into a family of Chinese immigrants in Port Elizabeth, Soon-Shiong earned his medical degree at the University of the Witwatersrand before fleeing apartheid for the U.S. in the 1980s. He made his first fortune by inventing Abraxane, a nanoparticle-delivered chemo drug that became a blockbuster, and later sold his pharma company to Celgene for $2.9 billion. But his true passion lies in the Nant ecosystem: a sprawling network of labs, data hubs, and clinical trials aiming to decode the immune system. This year, his NantKwest and ImmunityBio merger created a powerhouse with a pipeline of next-gen cell therapies, while his “Cancer Moonshot” collaborations with the Biden administration have drawn global praise.

Yet for all his boardroom bravado, Soon-Shiong is a man of quiet, fierce loyalty. He recently mourned the loss of Kay Patrick, the beloved Coronation Street director who died at 84—a reminder that even titans pause to honor artistry. As he blows out the candles, Soon-Shiong’s legacy is not just in billions but in breakthroughs: a world where pancreatic cancer, the disease that claimed Patrick’s fictional Hayley Cropper, might one day be vanquished. Here’s to a year of more miracles, more cures, and more reasons to celebrate the man who dares to heal the world.